Burlingame, CA – According to filings with the U.S. Securities and Exchange Commission, Color is raising $167,224,225.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Othman Laraki played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Color

Color is a leader in distributed healthcare and clinical testing. From population genomics programs to high-throughput COVID-19 testing, we provide the technology and infrastructure to power large-scale health initiatives. We work with health systems, employers, researchers, physicians and national health initiatives worldwide to drive positive health outcomes. Color’s mission is to help people lead the healthiest lives that science and medicine can offer. We launched in April 2015 with a simple, affordable genetic test to help people understand their risk for hereditary cancer. In 2017, we added coverage for hereditary heart conditions. Between them, cancer and heart disease constitute the two biggest causes of death worldwide. In September 2018, we introduced a new health area, medication response, to help people understand how their genes may influence response to certain medications.

To learn more about Color, visit http://www.color.com/

Contact:
Othman Laraki, Chief Executive Officer
650-651-7116
https://www.linkedin.com/in/othmanlaraki/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved